Welcome to PsychU!

Events

PsychU events are designed to provide a platform for discussion and a place to share knowledge and ideas about the latest information on mental health treatment. From online web briefings, to live events taking place throughout the country, PsychU events provide opportunities to learn about best practices in treatment, innovative ideas from other clinicians, management and operations advice, and the latest industry trends effecting the delivery of mental health services.

  1. Events
  2. National

Events Search and Views Navigation

Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Event Views Navigation

Today

Virtual Learning Session – Psychedelics For The Treatment Of Depression: Focus On 5HT-2A

National February 11, 2021 3:00pm to 4:00pm EST

Virtual Learning Session – Psychedelics For The Treatment Of Depression: Focus On 5HT-2A The presenters will discuss the history of psychedelics in therapeutic approaches with a primary focus on psilocybin. They will also review the neurobiology of psychedelics and the role of 5-HT2A receptors, review the results of recently published findings, and discuss the challenges […]

Virtual Event – Battle Of The Section Advisors – Rethinking Depression & Bipolar Disorders: A Spectrum Or Distinct Categories?

National March 23, 2021 12:00pm to 1:00pm EDT

PsychU members are invited to tune into a lively Point-Counterpoint between two experts in the field of bipolar disorders. There has been much discussion about depression and bipolar disorder being spectrum rather than discrete disorders. Dr. Fatima Sadat will moderate this debate between PsychU bipolar section advisors Dr. Terence Ketter and Dr. Joseph Goldberg as […]

Virtual Event – Psychedelics For The Treatment Of Depression: Focus On 5HT-2A

National April 15, 2021 6:30pm to 7:45pm EDT

Virtual Event - Psychedelics For The Treatment Of Depression: Focus On 5HT-2A The presenters will discuss the history of psychedelics in therapeutic approaches with a primary focus on psilocybin. They will also review the neurobiology of psychedelics and the role of 5-HT2A receptors, review the results of recently published findings, and discuss the challenges associated […]

Virtual Event – Anxiety In Major Depressive Disorder

National April 26, 2021 1:00pm to 2:00pm EDT

Virtual Event - Anxiety In Major Depressive Disorder Presenters explain the prevalence of anxiety in Major Depressive Disorder (MDD), discuss the clinical prognosis of comorbid anxiety with MDD, and identify rating scales that assess anxiety and MDD.

Virtual Event – Anxiety In Major Depressive Disorder

National April 26, 2021 3:00pm to 4:00pm EDT

Virtual Event - Anxiety In Major Depressive Disorder Presenters explain the prevalence of anxiety in Major Depressive Disorder (MDD), discuss the clinical prognosis of comorbid anxiety with MDD, and identify rating scales that assess anxiety and MDD.

Virtual Event – Antipsychotic Treatment Options In Schizophrenia

National May 05, 2021 1:00pm to 2:00pm EDT

Virtual Event - Antipsychotic Treatment Options In Schizophrenia The treatment of schizophrenia has evolved over the past half-century primarily in the context of antipsychotic drug development. In addition to reviewing the evolution of antipsychotic treatments for schizophrenia, in this virtual live event the speakers will discuss definitions of adherence and review possible reasons for nonadherence, […]

Virtual Event – Anxiety In Major Depressive Disorder

National May 18, 2021 1:00pm to 2:00pm EDT

Virtual Event - Anxiety In Major Depressive Disorder Presenters explain the prevalence of anxiety in Major Depressive Disorder (MDD), discuss the clinical prognosis of comorbid anxiety with MDD, and identify rating scales that assess anxiety and MDD.

Virtual Event – Psychedelics For The Treatment Of Depression: Focus On 5HT-2A

National May 19, 2021 12:00pm to 1:00pm EDT

Virtual Event - Psychedelics For The Treatment Of Depression: Focus On 5HT-2A The presenters will discuss the history of psychedelics in therapeutic approaches with a primary focus on psilocybin. They will also review the neurobiology of psychedelics and the role of 5-HT2A receptors, review the results of recently published findings, and discuss the challenges associated […]

Virtual Event – Inadequately Treated Major Depressive Disorder

National May 26, 2021 1:00pm to 2:00pm EDT

Virtual Event - Inadequately Treated Major Depressive Disorder The presentation highlights the importance of addressing inadequately treated major depressive disorder (MDD). The discussion will feature the prevalence and burden of inadequately treated MDD in the U.S., how inadequate treatment impacts long-term outcomes of MDD and possible treatment strategies.

Virtual Event – Inadequately Treated Major Depressive Disorder

National June 09, 2021 1:00pm to 2:00pm EDT

Virtual Event - Inadequately Treated Major Depressive Disorder The presentation highlights the importance of addressing inadequately treated major depressive disorder (MDD). The discussion will feature the prevalence and burden of inadequately treated MDD in the U.S., how inadequate treatment impacts long-term outcomes of MDD and possible treatment strategies.

Virtual Event – Inadequately Treated Major Depressive Disorder

National June 09, 2021 3:00pm to 4:00pm EDT

Virtual Event - Inadequately Treated Major Depressive Disorder The presentation highlights the importance of addressing inadequately treated major depressive disorder (MDD). The discussion will feature the prevalence and burden of inadequately treated MDD in the U.S., how inadequate treatment impacts long-term outcomes of MDD and possible treatment strategies.

Virtual Event – Management Of Major Depressive Disorder: Breaking Through The Barrier

National July 26, 2021 3:00pm to 4:00pm EDT

Virtual Event - Management Of Major Depressive Disorder: Breaking Through The Barrier An estimated 1 in 10 US adults report depression, with major depressive disorder (MDD) as common as diabetes or coronary artery disease. During this virtual event, Sanjai Rao, MD, Associate Clinical Professor and Associate Residency Training Director, University of California, San Diego, CA; […]

Virtual Event – Do Inflammation & Metabolic Disturbances Metastasize To The Brain? Implications For Disease Modeling & Novel Approaches In Psychiatry

National August 09, 2021 3:00pm to 4:00pm EDT

Virtual Event - Do Inflammation & Metabolic Disturbances Metastasize To The Brain? Implications For Disease Modeling & Novel Approaches In Psychiatry During this webinar, Dr. David Block, MD, MMM and Sucharita Somkuwar, PhD will discuss the effects of inflammation and metabolic disturbances on mood disorders in a national Virtual Event. The objectives of the presentation […]

Virtual Event – Importance of Adherence to Outcomes in Schizophrenia & Bipolar Disorder

National August 12, 2021 12:00pm to 1:00pm EDT

Importance of Adherence to Outcomes in Schizophrenia & Bipolar Disorder Nonadherence is a serious problem that can compromise treatment effectiveness in psychiatry. This presentation will review the multidimensional factors that contribute to adherence, discuss consequences of poor adherence, and bring to light implementation strategies to address adherence.

Virtual Event – Proposed Roles Of Modulating Norepinephrine In Psychiatric Illnesses

National September 01, 2021 1:00pm to 2:00pm EDT

Proposed Roles Of Modulating Norepinephrine In Psychiatric Illnesses Modulation of norepinephrine (NE) has become commonplace in understanding psychiatric illnesses and in therapeutic approaches. This presentation will investigate the complex overlap of monoamines and the role of NE in neuronal circuitry. The discussion will dive deep into the relationship between local NE concentration and receptor activation, […]

Virtual Event – Bipolar Disorder: Updates on Research & Clinical Outcomes

National October 19, 2021 1:00pm to 2:00pm EDT

Bipolar Disorder: Updates on Research and Clinical Outcomes This presentation details the multidimensional nature of bipolar disorder and highlights the wide spectrum of associated manic and depressive symptoms. The discussion will review the brain anatomical correlation of symptoms as well as the underlying pathophysiological theories. Furthermore, the impact of residual symptoms on clinical outcomes, on […]

Virtual Event – Antipsychotic Treatment Options in Schizophrenia

National November 02, 2021 3:00pm to 4:00pm EDT
The treatment of schizophrenia has evolved over the past half-century primarily in the context of antipsychotic drug development. In addition to reviewing the evolution of antipsychotic treatments for schizophrenia, in this virtual live event the speakers will discuss definitions of adherence and review possible reasons for nonadherence, as well as...

On-Demand Webinars

REQUEST A PRESENTATION

Request a free educational program for your organization or region today! These customizable PsychU presentations are available both online and in-person, and cover a range of topics including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and more.

Top Requested Presentations

Social Determinants Of Health

Agitation Associated With Alzheimer’s Dementia Disease State Education

The Importance Of Population Health: A Mental Health Perspective

Learning Tracks